The JDRF New England Chapter would like to thank Type 1 Diabetes TrialNet for joining us this past weekend at the JDRF One Walks in Boston and Lancaster!  Committed in their mission to delay—and ultimately stop—the progression of type 1 diabetes (T1D), the TrialNet team is comprised of researchers and physicians dedicated to the study and early treatment of T1D.  Thanks to more than 160,000 volunteers that have participate in TrialNet funded research projects, scientists have a better understanding of who may be at risk for developing T1D and how they might delay a clinical diagnosis.

JDRF is proud to partner with TrialNet as we work to create a world without type 1 diabetes.  At present, 1.25 million Americans are living with T1D, and it is expected that as many as 5 million Americans will have type 1 diabetes by 2050.  JDRF is working hard to change that possibility by funding research that would not only delay the initial onset of T1D, but would prevent anyone else from ever knowing it.

If you will be walking with us in New Bedford, MA on Saturday, October 14 or East Greenwich, RI on Sunday, October 15, we invite you to stop by and learn more about TrialNet and see how you can get involved!  You are eligible for screening if you are between ages 1 and 45 and have a parent, child, brother, or sister with T1D or if you are between age 1 and 20 and have a niece, nephew, aunt, uncle, grandparent, half-brother, half-sister, or cousin with type 1 diabetes.

TrialNet is supported by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, JDRF, American Diabetes Association, and Helmsley Charitable Trust.  Visit www.trialnet.org to learn more.